Q2 estimates down on lower production from the Tie field Drilling campaign to commence in Oman fro...
Rovio will publish its Q2 report on 11 August at 9:00 EET.
Redeye leaves its view on Xspray following friday's Q2 report, where it announced a vision of genera...
Scanfil’s Q2 report didn’t reveal big surprises, although there were a couple of profitability headw...
Safe at Sea tillverkar sök- och livräddningsbåtar för SAR-verksamhet (Search and Rescue).
Relais issued a profit warning and pre-released Q2 numbers this morning.
We raise our full-year group clean EBIT forecast by ~50%.
Revenue growth was in line with expectations but operating profit was 10% lower than Refinitiv conse...
Redeye considers BIMobject’s figures to be overall in line with our expectations, but mainly driven ...
EAB reported H1 comparable operating income of EUR 14.
Redeye is positive about the work done by Moberg Pharma to further strengthen their partner network ...
CapMan showed good progress across the board in Q2.
Scanfil’s Q2 report didn’t serve any major surprises.
Isofol Medical announced that the phase III trial AGENT had failed to reach its primary and most imp...
Profit before tax at DKK 54m, 8% above ABGSCe Growth in Greenland on track Strong quarter on insur...
We expect a solid Q2 report on 26 August with group sales growing 26% y/y to SEK 182m, driven by M&A...
Following BankNordik's Q2 2022 report, we lift 2022E-24E adjusted EPS by ~1%, primarily due to impro...
Redeye endorses Genovis entering into a service agreement with evitria AG for LC-MS analysis of reco...
Enersense’s Q2 results were known before the official release as the company disclosed preliminary f...
Redeye comments on Active Biotech's second quarter report and the rights issue that was simultaneous...
